BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19675138)

  • 1. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
    Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
    Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of lipid metabolism by glucocorticoids and 11β-HSD1 in skeletal muscle.
    Morgan SA; Gathercole LL; Simonet C; Hassan-Smith ZK; Bujalska I; Guest P; Abrahams L; Smith DM; Stewart PM; Lavery GG; Tomlinson JW
    Endocrinology; 2013 Jul; 154(7):2374-84. PubMed ID: 23633532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
    Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
    J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
    Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
    Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1.
    Biedasek K; Andres J; Mai K; Adams S; Spuler S; Fielitz J; Spranger J
    PLoS One; 2011 Jan; 6(1):e16674. PubMed ID: 21304964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and dexamethasone dynamically regulate adipocyte 11beta-hydroxysteroid dehydrogenase type 1.
    Balachandran A; Guan H; Sellan M; van Uum S; Yang K
    Endocrinology; 2008 Aug; 149(8):4069-79. PubMed ID: 18467433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.
    Park SY; Bae JH; Cho YS
    Cell Biochem Funct; 2014 Apr; 32(3):249-57. PubMed ID: 24122936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts.
    Sun K; Myatt L
    Endocrinology; 2003 Dec; 144(12):5568-77. PubMed ID: 12960005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.
    Michas G; Liberman M; Becker KC; Handy DE; Loscalzo J; Leopold JA
    Mol Cell Biochem; 2011 Jan; 346(1-2):69-79. PubMed ID: 20922465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
    Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
    Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome.
    Loerz C; Maser E
    J Steroid Biochem Mol Biol; 2017 Nov; 174():65-71. PubMed ID: 28765040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.
    Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ
    Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
    Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
    Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast.
    Sun K; He P; Yang K
    Biol Reprod; 2002 Nov; 67(5):1450-5. PubMed ID: 12390875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of 11beta-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes.
    Zhang M; Lv XY; Li J; Xu ZG; Chen L
    Mol Cell Biochem; 2009 Apr; 324(1-2):147-55. PubMed ID: 19118409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11β-HSD1 contributes to age-related metabolic decline in male mice.
    Morgan SA; Gathercole LL; Hassan-Smith ZK; Tomlinson J; Stewart PM; Lavery GG
    J Endocrinol; 2022 Dec; 255(3):117-129. PubMed ID: 36205523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
    Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
    Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.